Overview

Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to measure effects of the combined treatment with GH and IGF-I on glucose sensitivity and body composition in patients with GHD and IGT or diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
Karolinska University Hospital
Treatments:
Mecasermin